These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23016828)

  • 1. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease.
    Tjellström B; Högberg L; Stenhammar L; Magnusson KE; Midtvedt T; Norin E; Sundqvist T
    Scand J Gastroenterol; 2012 Dec; 47(12):1454-9. PubMed ID: 23016828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition.
    Gerasimidis K; Bertz M; Hanske L; Junick J; Biskou O; Aguilera M; Garrick V; Russell RK; Blaut M; McGrogan P; Edwards CA
    Inflamm Bowel Dis; 2014 May; 20(5):861-71. PubMed ID: 24651582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease.
    Copova I; Hradsky O; Zarubova K; Gonsorcikova L; Potuznikova K; Lerchova T; Nevoral J; Bronsky J
    Eur J Pediatr; 2018 Nov; 177(11):1685-1693. PubMed ID: 30128744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.
    Svolos V; Hansen R; Nichols B; Quince C; Ijaz UZ; Papadopoulou RT; Edwards CA; Watson D; Alghamdi A; Brejnrod A; Ansalone C; Duncan H; Gervais L; Tayler R; Salmond J; Bolognini D; Klopfleisch R; Gaya DR; Milling S; Russell RK; Gerasimidis K
    Gastroenterology; 2019 Apr; 156(5):1354-1367.e6. PubMed ID: 30550821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exclusive enteral nutrition remodels the intestinal flora in patients with active Crohn's disease.
    Jiang J; Chen L; Chen Y; Chen H
    BMC Gastroenterol; 2022 Apr; 22(1):212. PubMed ID: 35501724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive Modulation of the Fecal Metagenome in Children With Crohn's Disease During Exclusive Enteral Nutrition.
    Quince C; Ijaz UZ; Loman N; Eren AM; Saulnier D; Russell J; Haig SJ; Calus ST; Quick J; Barclay A; Bertz M; Blaut M; Hansen R; McGrogan P; Russell RK; Edwards CA; Gerasimidis K
    Am J Gastroenterol; 2015 Dec; 110(12):1718-29; quiz 1730. PubMed ID: 26526081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of exclusive enteral nutrition in paediatric Crohn's disease in The Netherlands.
    de Bie C; Kindermann A; Escher J
    J Crohns Colitis; 2013 May; 7(4):263-70. PubMed ID: 22820027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review.
    MacLellan A; Moore-Connors J; Grant S; Cahill L; Langille MGI; Van Limbergen J
    Nutrients; 2017 May; 9(5):. PubMed ID: 28468301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards an integrated understanding of the therapeutic utility of exclusive enteral nutrition in the treatment of Crohn's disease.
    Cuív PÓ; Begun J; Keely S; Lewindon PJ; Morrison M
    Food Funct; 2016 Apr; 7(4):1741-51. PubMed ID: 26948398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
    Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
    J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal Healing and Bacterial Composition in Response to Enteral Nutrition Vs Steroid-based Induction Therapy-A Randomised Prospective Clinical Trial in Children With Crohn's Disease.
    Pigneur B; Lepage P; Mondot S; Schmitz J; Goulet O; Doré J; Ruemmele FM
    J Crohns Colitis; 2019 Jul; 13(7):846-855. PubMed ID: 30541015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn's disease: a meta-analysis.
    Yu Y; Chen KC; Chen J
    World J Pediatr; 2019 Feb; 15(1):26-36. PubMed ID: 30666565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study.
    Urlep D; Benedik E; Brecelj J; Orel R
    Eur J Pediatr; 2020 Mar; 179(3):431-438. PubMed ID: 31781933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
    Levine A; Wine E; Assa A; Sigall Boneh R; Shaoul R; Kori M; Cohen S; Peleg S; Shamaly H; On A; Millman P; Abramas L; Ziv-Baran T; Grant S; Abitbol G; Dunn KA; Bielawski JP; Van Limbergen J
    Gastroenterology; 2019 Aug; 157(2):440-450.e8. PubMed ID: 31170412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
    Day AS; Whitten KE; Lemberg DA; Clarkson C; Vitug-Sales M; Jackson R; Bohane TD
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1609-14. PubMed ID: 16928225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusive enteral nutritional therapy can relieve inflammatory bowel stricture in Crohn's disease.
    Hu D; Ren J; Wang G; Li G; Liu S; Yan D; Gu G; Zhou B; Wu X; Chen J; Ding C; Wu Y; Wu Q; Liu N; Li J
    J Clin Gastroenterol; 2014 Oct; 48(9):790-5. PubMed ID: 24440935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics].
    Navas-López VM; Blasco-Alonso J; Lacasa Maseri S; Girón Fernández-Crehuet F; Serrano Nieto MJ; Vicioso Recio MI; Sierra Salinas C
    An Pediatr (Barc); 2015 Jul; 83(1):47-54. PubMed ID: 24704330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition.
    Nahidi L; Leach ST; Sidler MA; Levin A; Lemberg DA; Day AS
    Inflamm Bowel Dis; 2011 Feb; 17(2):516-23. PubMed ID: 20848544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn's disease.
    Nichols B; Briola A; Logan M; Havlik J; Mascellani A; Gkikas K; Milling S; Ijaz UZ; Quince C; Svolos V; Russell RK; Hansen R; Gerasimidis K
    Am J Clin Nutr; 2024 Apr; 119(4):885-895. PubMed ID: 38569785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn's disease.
    Cameron FL; Gerasimidis K; Papangelou A; Missiou D; Garrick V; Cardigan T; Buchanan E; Barclay AR; McGrogan P; Russell RK
    Aliment Pharmacol Ther; 2013 Mar; 37(6):622-9. PubMed ID: 23360085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.